Lea Grote‐Levi

472 total citations
19 papers, 228 citations indexed

About

Lea Grote‐Levi is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Lea Grote‐Levi has authored 19 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in Lea Grote‐Levi's work include Multiple Sclerosis Research Studies (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Polyomavirus and related diseases (3 papers). Lea Grote‐Levi is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Polyomavirus and related diseases (3 papers). Lea Grote‐Levi collaborates with scholars based in Germany, Switzerland and Slovakia. Lea Grote‐Levi's co-authors include Eoin O’Connell, Sabrina Thum, Nadezhda Glezeva, Thomas Thum, Chris Watson, J. Gallagher, Kenneth McDonald, Mark Ledwidge, Shashi Kumar Gupta and Nora Möhn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Heart Journal.

In The Last Decade

Lea Grote‐Levi

11 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lea Grote‐Levi Germany 6 97 95 86 40 29 19 228
Geraldine E. Malana United States 2 128 1.3× 194 2.0× 103 1.2× 16 0.4× 18 0.6× 3 296
Jake Cosme Canada 7 41 0.4× 133 1.4× 62 0.7× 15 0.4× 7 0.2× 9 209
Laurence Servais Belgium 7 77 0.8× 91 1.0× 105 1.2× 54 1.4× 4 0.1× 10 256
Runda Wu China 7 71 0.7× 182 1.9× 73 0.8× 23 0.6× 4 0.1× 21 280
Janet Remke Germany 3 263 2.7× 290 3.1× 109 1.3× 19 0.5× 9 0.3× 4 406
Philyoung Lee United States 8 100 1.0× 325 3.4× 141 1.6× 12 0.3× 15 0.5× 8 416
Dena Esfandyari Germany 3 135 1.4× 203 2.1× 117 1.4× 14 0.3× 7 0.2× 3 293
Steffen Rump Germany 4 227 2.3× 303 3.2× 119 1.4× 20 0.5× 7 0.2× 8 420
Yingnan Liao China 7 27 0.3× 226 2.4× 126 1.5× 18 0.5× 8 0.3× 9 319

Countries citing papers authored by Lea Grote‐Levi

Since Specialization
Citations

This map shows the geographic impact of Lea Grote‐Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Grote‐Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Grote‐Levi more than expected).

Fields of papers citing papers by Lea Grote‐Levi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea Grote‐Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Grote‐Levi. The network helps show where Lea Grote‐Levi may publish in the future.

Co-authorship network of co-authors of Lea Grote‐Levi

This figure shows the co-authorship network connecting the top 25 collaborators of Lea Grote‐Levi. A scholar is included among the top collaborators of Lea Grote‐Levi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea Grote‐Levi. Lea Grote‐Levi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Konen, Franz Felix, Torsten Witte, Diana Ernst, et al.. (2025). Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis. Neurological Research and Practice. 7(1). 48–48.
2.
Konen, Franz Felix, Tabea Seeliger, Konstantin Fritz Jendretzky, et al.. (2025). Idiopathic inflammatory myopathy associated with Sjögren’s disease: features of a distinct clinical entity. Frontiers in Immunology. 16. 1654576–1654576.
3.
Grote‐Levi, Lea, Anja Hänselmann, Sandra Nay, et al.. (2025). Polyneuropathy in hereditary and wildtype transthyretin amyloidosis, comparison of key clinical features and red flags. Scientific Reports. 15(1). 35028–35028.
4.
Konen, Franz Felix, Nora Möhn, Lea Grote‐Levi, et al.. (2025). Neuroborreliosis with encephalitis: a broad spectrum of clinical manifestations. BMC Infectious Diseases. 25(1). 182–182. 1 indexed citations
5.
Möhn, Nora, Thomas Skripuletz, S. Carl, et al.. (2025). Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events. Journal of Neurology. 272(7). 459–459.
6.
Konen, Franz Felix, Martin W. Hümmert, Philipp Schwenkenbecher, et al.. (2025). Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab. Neurological Research and Practice. 7(1). 58–58.
7.
Konen, Franz Felix, Stefan Gingele, Martin W. Hümmert, et al.. (2024). Rapid depletion of CD20+ B and T cells following ofatumumab therapy onset. Multiple Sclerosis and Related Disorders. 91. 105886–105886. 1 indexed citations
8.
Möhn, Nora, Sandra Nay, Philipp Schwenkenbecher, et al.. (2024). Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas. Journal of Neurology. 271(10). 6970–6982. 1 indexed citations
9.
Nay, Sandra, Nora Möhn, Lea Grote‐Levi, et al.. (2024). Combined treatment with allogeneic Epstein–Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report. Therapeutic Advances in Neurological Disorders. 17. 4233535005–4233535005.
10.
Schwenkenbecher, Philipp, Lea Grote‐Levi, Roland Merten, et al.. (2024). Radiotherapy in patients with brain metastases with and without concomitant immunotherapy: comparison of patient outcome and neurotoxicity. Discover Oncology. 15(1). 656–656.
11.
Möhn, Nora, Lea Grote‐Levi, Tabea Seeliger, et al.. (2023). Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity. Cancer Medicine. 12(8). 9373–9383. 18 indexed citations
12.
Grote‐Levi, Lea, Nora Möhn, Agnes Bonifacius, et al.. (2023). Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy. Neurology Neuroimmunology & Neuroinflammation. 10(5). 1 indexed citations
13.
Möhn, Nora, Lea Grote‐Levi, Franziska Hopfner, et al.. (2022). Innovative therapeutic concepts of progressive multifocal leukoencephalopathy. Journal of Neurology. 269(5). 2403–2413. 8 indexed citations
14.
Konen, Franz Felix, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, et al.. (2022). Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications. Cells. 11(14). 2165–2165. 5 indexed citations
15.
Möhn, Nora, Lea Grote‐Levi, Victoria Panagiota, et al.. (2022). Neurological management and work-up of neurotoxicity associated with CAR T cell therapy. SHILAP Revista de lepidopterología. 4(1). 1–1. 18 indexed citations
16.
Möhn, Nora, Lea Grote‐Levi, & Thomas Skripuletz. (2022). Diagnose und Therapie der Multiplen Sklerose. 5(4). 292–300.
17.
Schimmel, Katharina, Stevan D. Stojanović, Cheng-Kai Huang, et al.. (2020). Combined high-throughput library screening and next generation RNA sequencing uncover microRNAs controlling human cardiac fibroblast biology. Journal of Molecular and Cellular Cardiology. 150. 91–100. 13 indexed citations
18.
Schimmel, Katharina, Lea Grote‐Levi, Ke Xiao, et al.. (2017). P2308Natural compound library screen identifies potent molecules with anti-fibrotic activity through modulation of noncoding RNAs. European Heart Journal. 38(suppl_1). 1 indexed citations
19.
Watson, Chris, Shashi Kumar Gupta, Eoin O’Connell, et al.. (2015). MicroRNA Signatures Differentiate Preserved from Reduced Ejection Fraction Heart Failure. European Journal of Heart Failure. 17(4). 405–415. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geraldine E. Malana Breakdown of academic impact, for papers by Jake Cosme Breakdown of academic impact, for papers by Laurence Servais Breakdown of academic impact, for papers by Runda Wu Breakdown of academic impact, for papers by Janet Remke Breakdown of academic impact, for papers by Philyoung Lee Breakdown of academic impact, for papers by Dena Esfandyari Breakdown of academic impact, for papers by Steffen Rump Breakdown of academic impact, for papers by Yingnan Liao
Rankless by CCL
2026